Australasia / AUSTRALIA
To continue to view the full report
Buy this company's report, or subscribe to a plan.
Company Overview
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Commercial Services & Supplies |
| Sub Industry | Commercial Physical Research |
| Country | AUSTRALIA |
| Employees | n/a |
| Reporting Unit | Millions |
| Primary Exchange | DUS FRA HAM BLN ASX |
| Instrument Type | Equity |
| Website | http://www.bioxyne.com |
| Wright ID | C036BYL9H |
Key Metrics
| Current price | $0.99 |
| Market cap | $232.5 M |
| P/E ratio | 14.70 |
| 52-week perf. | +146.3% |
| Common shares | 236.1 M |
| Closely held | 161.2 M |
| Share type | Ordinary |
| Quality rating | LAB20 |
| Dividend yield | 0.00% |
Recent stock performance
| 1 Week | -3.9% |
| 4 Week | -3.4% |
| 13 Week | +21.6% |
Officers
| Chairman | Anthony Ho |
| Chief Executive & Managing Director | Nam Hoat Chua |
| Chief Financial Officer, Chief Operating Officer & Secretary | Guy Adrian Robertson |
Address
SE 506 L 5 50 Clarence Street
SYDNEY, New South Wales
AUSTRALIA
2000
| Phone | n/a |
Quarterly Earnings & Dividends
Try another report for annual statements, Wright Quality history or comparative analysis.